Association of Programmed Death-Ligand 1 Expression with Aggressive Histological Types of Thyroid Carcinoma

INTRODUCTION: Immunohistochemical expression of programmed death-ligand 1 (PD-L1) has become a biomarker to predict the usefulness of cancer immunotherapy using PD-1/PD-L1 blockade in a variety of advanced-stage tumours. This emerging biomarker may serve to generate novel therapies for aggressive th...

Descripción completa

Detalles Bibliográficos
Autores principales: Harahap, Agnes Stephanie, Lay, Fanny Kamarudy, Kodariah, Ria, Wongkar, Fresia Juwitasari, Ham, Maria Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793731/
https://www.ncbi.nlm.nih.gov/pubmed/36583030
http://dx.doi.org/10.2147/CMAR.S392475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793731/
https://www.ncbi.nlm.nih.gov/pubmed/36583030
http://dx.doi.org/10.2147/CMAR.S392475

Ejemplares similares